Onureg (BMS)
-
Leucemia
FDA aprueba Onureg (BMS), terapia oral para leucemia mieloide aguda
Bristol Myers Squibb ha anunciado que la Food and Drug Administration (FDA) de EE.UU. ha aprobado Onureg (azacitidina 300 mg comprimidos,…
Bristol Myers Squibb ha anunciado que la Food and Drug Administration (FDA) de EE.UU. ha aprobado Onureg (azacitidina 300 mg comprimidos,…
| Cookie | Duración | Descripción |
|---|---|---|
| cookielawinfo-checkbox-analytics | 11 months | This cookie is set by GDPR Cookie Consent plugin. The cookie is used to store the user consent for the cookies in the category "Analytics". |
| cookielawinfo-checkbox-functional | 11 months | The cookie is set by GDPR cookie consent to record the user consent for the cookies in the category "Functional". |
| cookielawinfo-checkbox-necessary | 11 months | This cookie is set by GDPR Cookie Consent plugin. The cookies is used to store the user consent for the cookies in the category "Necessary". |
| cookielawinfo-checkbox-others | 11 months | This cookie is set by GDPR Cookie Consent plugin. The cookie is used to store the user consent for the cookies in the category "Other. |
| cookielawinfo-checkbox-performance | 11 months | This cookie is set by GDPR Cookie Consent plugin. The cookie is used to store the user consent for the cookies in the category "Performance". |
| viewed_cookie_policy | 11 months | The cookie is set by the GDPR Cookie Consent plugin and is used to store whether or not user has consented to the use of cookies. It does not store any personal data. |